Univercells Technologies at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Univercells Technologies brings 2 presentations to ESGCT 2026 in Hamburg. Its contribution centres on fixed-bed bioreactor culture for biomanufacturing. Work shows the approach raising yield and product quality while improving cost for lentiviral vector production and for extracellular vesicles made by mesenchymal stem cells.
| Organization | ESGCT 2026 Attendance |
|---|---|
Univercells Technologies Nivelles, Belgium | |
Makes intensified bioprocess equipment, including scale-X fixed-bed bioreactors and the NevoLine platform, for viral vector and other biomanufacturing. Part of Donaldson. | Poster Wed Oct 28 1:30pm–3:30pm Biology‑Aligned Fixed‑Bed Bioreactor Culture Enhances Yield, Phenotypic Quality, and Manufacturing Economics of Mesenchymal Stem Cell–Derived Extracellular Vesicles Poster Wed Oct 28 1:30pm–3:30pm Scaling Lentiviral Vector Manufacturing Without Trade‑Offs: A Biology‑Aligned Fixed‑Bed Approach Improving Productivity, Product Quality, and Cost Efficiency |
Instantly find 20 buyers from Univercells Technologies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction